APO Research
Talk to an analyst

APO RESEARCH · REPORT

Embolization Particle

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Selected research

Market Outlook & Growth Opportunities

Global Embolization Particle Market Outlook and Growth Opportunities 2026

26 December 2025196 pages

Choose your research edition.

Industry ResearchEmbolization Particle Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Embolization Particle Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Embolization Particle Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Embolization Particle Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Embolization Particle Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

North America is the largest region of Embolization Particle, with a market share about 40%. It was followed by Europe with 30%. Sirtex Medical, Merit Medical, Cook Medical, BTG Medical and Boston Scientific Corporation are the top 5 manufacturers of industry, and they had about 80% combined market share.

This report provides an overview of the global Embolization Particle market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Embolization Particle and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Embolization Particle sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Embolization Particle market size, projected growth trends, production technologies, key applications, and end-use industries.

Embolization Particle Segment by Company

Sirtex Medical

Merit Medical

Cook Medical

BTG Medical

Boston Scientific Corporation

Terumo Corporation

HENGRUI Medical

INterface BIOmaterials B.V.

Alicon

Embolization Particle Segment by Type

Microspheres

Particles (e.g. PVA Particles, Gelfoam Particles)

Drug-eluting Beads (DEBs)

Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Embolization Particle Segment by Application

Uterine Fibroid Embolization

Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

Liver Tumor Embolization

Trauma Embolization

Others

Embolization Particle Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Embolization Particle status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Embolization Particle market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Embolization Particle significant trends, drivers, influence factors in global and regions.

6. To analyze Embolization Particle competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Embolization Particle market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Embolization Particle and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Embolization Particle.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Embolization Particle market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Embolization Particle industry.

Chapter 3: Detailed analysis of Embolization Particle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Embolization Particle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Embolization Particle in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Embolization Particle Industry Trends Table 2. Embolization Particle Industry Drivers Table 3. Embolization Particle Industry Opportunities and Challenges Table 4. Embolization Particle Industry Restraints Table 5. Global Embolization Particle Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Embolization Particle Revenue Share by Company (2021-2026) Table 7. Global Embolization Particle Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Embolization Particle Sales Volume Share by Company (2021-2026) Table 9. Global Embolization Particle Average Price (USD/Unit) of Company (2021-2026) Table 10. Global Embolization Particle Company Ranking, (2024-2026) & (USD Million) Table 11. Global Embolization Particle Key Company Manufacturing Base & Headquarters Table 12. Global Embolization Particle Company, Product Type & Application Table 13. Global Embolization Particle Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Embolization Particle by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microspheres Table 18. Significant Companies of Particles (e.g. PVA Particles, Gelfoam Particles) Table 19. Significant Companies of Drug-eluting Beads (DEBs) Table 20. Significant Companies of Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Table 21. Global Embolization Particle Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Embolization Particle Sales Volume by Type (2021-2026) & (K Units) Table 23. Global Embolization Particle Sales Volume by Type (2027-2032) & (K Units) Table 24. Global Embolization Particle Sales Volume Share by Type (2021-2026) Table 25. Global Embolization Particle Sales Volume Share by Type (2027-2032) Table 26. Global Embolization Particle Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Embolization Particle Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Embolization Particle Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Embolization Particle Sales Value Share by Type (2021-2026) Table 30. Global Embolization Particle Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Uterine Fibroid Embolization Table 32. Significant Companies of Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Table 33. Significant Companies of Liver Tumor Embolization Table 34. Significant Companies of Trauma Embolization Table 35. Significant Companies of Others Table 36. Global Embolization Particle Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Embolization Particle Sales Volume by Application (2021-2026) & (K Units) Table 38. Global Embolization Particle Sales Volume by Application (2027-2032) & (K Units) Table 39. Global Embolization Particle Sales Volume Share by Application (2021-2026) Table 40. Global Embolization Particle Sales Volume Share by Application (2027-2032) Table 41. Global Embolization Particle Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Embolization Particle Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Embolization Particle Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Embolization Particle Sales Value Share by Application (2021-2026) Table 45. Global Embolization Particle Sales Value Share by Application (2027-2032) Table 46. Global Embolization Particle Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Embolization Particle Sales by Region (2021-2026) & (K Units) Table 48. Global Embolization Particle Sales Market Share by Region (2021-2026) Table 49. Global Embolization Particle Sales by Region (2027-2032) & (K Units) Table 50. Global Embolization Particle Sales Market Share by Region (2027-2032) Table 51. Global Embolization Particle Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Embolization Particle Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Embolization Particle Sales Value Share by Region (2021-2026) Table 54. Global Embolization Particle Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Embolization Particle Sales Value Share by Region (2027-2032) Table 56. Global Embolization Particle Market Average Price (USD/Unit) by Region (2021-2026) Table 57. Global Embolization Particle Market Average Price (USD/Unit) by Region (2027-2032) Table 58. Global Embolization Particle Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. Global Embolization Particle Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Embolization Particle Sales by Country (2021-2026) & (K Units) Table 61. Global Embolization Particle Sales Market Share by Country (2021-2026) Table 62. Global Embolization Particle Sales by Country (2027-2032) & (K Units) Table 63. Global Embolization Particle Sales Market Share by Country (2027-2032) Table 64. Global Embolization Particle Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Embolization Particle Sales Value Market Share by Country (2021-2026) Table 66. Global Embolization Particle Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Embolization Particle Sales Value Market Share by Country (2027-2032) Table 68. Sirtex Medical Company Information Table 69. Sirtex Medical Business Overview Table 70. Sirtex Medical Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 71. Sirtex Medical Embolization Particle Product Portfolio Table 72. Sirtex Medical Recent Development Table 73. Merit Medical Company Information Table 74. Merit Medical Business Overview Table 75. Merit Medical Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Merit Medical Embolization Particle Product Portfolio Table 77. Merit Medical Recent Development Table 78. Cook Medical Company Information Table 79. Cook Medical Business Overview Table 80. Cook Medical Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Cook Medical Embolization Particle Product Portfolio Table 82. Cook Medical Recent Development Table 83. BTG Medical Company Information Table 84. BTG Medical Business Overview Table 85. BTG Medical Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. BTG Medical Embolization Particle Product Portfolio Table 87. BTG Medical Recent Development Table 88. Boston Scientific Corporation Company Information Table 89. Boston Scientific Corporation Business Overview Table 90. Boston Scientific Corporation Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Boston Scientific Corporation Embolization Particle Product Portfolio Table 92. Boston Scientific Corporation Recent Development Table 93. Terumo Corporation Company Information Table 94. Terumo Corporation Business Overview Table 95. Terumo Corporation Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Terumo Corporation Embolization Particle Product Portfolio Table 97. Terumo Corporation Recent Development Table 98. HENGRUI Medical Company Information Table 99. HENGRUI Medical Business Overview Table 100. HENGRUI Medical Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. HENGRUI Medical Embolization Particle Product Portfolio Table 102. HENGRUI Medical Recent Development Table 103. INterface BIOmaterials B.V. Company Information Table 104. INterface BIOmaterials B.V. Business Overview Table 105. INterface BIOmaterials B.V. Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. INterface BIOmaterials B.V. Embolization Particle Product Portfolio Table 107. INterface BIOmaterials B.V. Recent Development Table 108. Alicon Company Information Table 109. Alicon Business Overview Table 110. Alicon Embolization Particle Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Alicon Embolization Particle Product Portfolio Table 112. Alicon Recent Development Table 113. Key Raw Materials Table 114. Raw Materials Key Suppliers Table 115. Embolization Particle Distributors List Table 116. Embolization Particle Customers List Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. Embolization Particle Product Image Figure 2. Global Embolization Particle Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Embolization Particle Sales Value (2021-2032) & (US$ Million) Figure 4. Global Embolization Particle Sales (2021-2032) & (K Units) Figure 5. Global Embolization Particle Sales Average Price (USD/Unit) & (2021-2032) Figure 6. Global Embolization Particle Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microspheres Image Figure 10. Particles (e.g. PVA Particles, Gelfoam Particles) Image Figure 11. Drug-eluting Beads (DEBs) Image Figure 12. Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Image Figure 13. Global Embolization Particle Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Embolization Particle Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Embolization Particle Sales Volume Share by Type (2021-2032) Figure 16. Global Embolization Particle Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Embolization Particle Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Embolization Particle Sales Value Share by Type (2021-2032) Figure 19. Uterine Fibroid Embolization Image Figure 20. Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Image Figure 21. Liver Tumor Embolization Image Figure 22. Trauma Embolization Image Figure 23. Others Image Figure 24. Global Embolization Particle Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Embolization Particle Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Embolization Particle Sales Volume Share by Application (2021-2032) Figure 27. Global Embolization Particle Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Embolization Particle Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Embolization Particle Sales Value Share by Application (2021-2032) Figure 30. Global Embolization Particle Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 31. Global Embolization Particle Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Embolization Particle Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Embolization Particle Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Embolization Particle Sales Value (2021-2032) & (US$ Million) Figure 35. North America Embolization Particle Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Embolization Particle Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Embolization Particle Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Embolization Particle Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Embolization Particle Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Embolization Particle Sales Value (2021-2032) & (US$ Million) Figure 41. South America Embolization Particle Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Embolization Particle Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Embolization Particle Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Embolization Particle Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Embolization Particle Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Embolization Particle Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Embolization Particle Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Embolization Particle Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Microspheres
  • Particles (e.g. PVA Particles, Gelfoam Particles)
  • Drug-eluting Beads (DEBs)
  • Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Applications
  • Uterine Fibroid Embolization
  • Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  • Liver Tumor Embolization
  • Trauma Embolization
  • Others
Companies covered
  • Sirtex Medical
  • Merit Medical
  • Cook Medical
  • BTG Medical
  • Boston Scientific Corporation
  • Terumo Corporation
  • HENGRUI Medical
  • INterface BIOmaterials B.V.
  • Alicon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Embolization Particle Sales Value (2021-2032)
  4. 1.2.2 Global Embolization Particle Sales Volume (2021-2032)
  5. 1.2.3 Global Embolization Particle Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Embolization Particle Market Dynamics
  1. 2.1 Embolization Particle Industry Trends
  2. 2.2 Embolization Particle Industry Drivers
  3. 2.3 Embolization Particle Industry Opportunities and Challenges
  4. 2.4 Embolization Particle Industry Restraints
3 Embolization Particle Market by Company
  1. 3.1 Global Embolization Particle Company Revenue Ranking in 2025
  2. 3.2 Global Embolization Particle Revenue by Company (2021-2026)
  3. 3.3 Global Embolization Particle Sales Volume by Company (2021-2026)
  4. 3.4 Global Embolization Particle Average Price by Company (2021-2026)
  5. 3.5 Global Embolization Particle Company Ranking (2024-2026)
  6. 3.6 Global Embolization Particle Company Manufacturing Base and Headquarters
  7. 3.7 Global Embolization Particle Company Product Type and Application
  8. 3.8 Global Embolization Particle Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Embolization Particle Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Embolization Particle Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Embolization Particle Market by Type
  1. 4.1 Embolization Particle Type Introduction
  2. 4.1.1 Microspheres
  3. 4.1.2 Particles (e.g. PVA Particles, Gelfoam Particles)
  4. 4.1.3 Drug-eluting Beads (DEBs)
  5. 4.1.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
  6. 4.2 Global Embolization Particle Sales Volume by Type
  7. 4.2.1 Global Embolization Particle Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Embolization Particle Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Embolization Particle Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Embolization Particle Sales Value by Type
  11. 4.3.1 Global Embolization Particle Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Embolization Particle Sales Value by Type (2021-2032)
  13. 4.3.3 Global Embolization Particle Sales Value Share by Type (2021-2032)
5 Embolization Particle Market by Application
  1. 5.1 Embolization Particle Application Introduction
  2. 5.1.1 Uterine Fibroid Embolization
  3. 5.1.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
  4. 5.1.3 Liver Tumor Embolization
  5. 5.1.4 Trauma Embolization
  6. 5.1.5 Others
  7. 5.2 Global Embolization Particle Sales Volume by Application
  8. 5.2.1 Global Embolization Particle Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Embolization Particle Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Embolization Particle Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Embolization Particle Sales Value by Application
  12. 5.3.1 Global Embolization Particle Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Embolization Particle Sales Value by Application (2021-2032)
  14. 5.3.3 Global Embolization Particle Sales Value Share by Application (2021-2032)
6 Embolization Particle Regional Sales and Value Analysis
  1. 6.1 Global Embolization Particle Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Embolization Particle Sales by Region (2021-2032)
  3. 6.2.1 Global Embolization Particle Sales by Region: 2021-2026
  4. 6.2.2 Global Embolization Particle Sales by Region (2027-2032)
  5. 6.3 Global Embolization Particle Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Embolization Particle Sales Value by Region (2021-2032)
  7. 6.4.1 Global Embolization Particle Sales Value by Region: 2021-2026
  8. 6.4.2 Global Embolization Particle Sales Value by Region (2027-2032)
  9. 6.5 Global Embolization Particle Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Embolization Particle Sales Value (2021-2032)
  12. 6.6.2 North America Embolization Particle Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Embolization Particle Sales Value (2021-2032)
  15. 6.7.2 Europe Embolization Particle Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Embolization Particle Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Embolization Particle Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Embolization Particle Sales Value (2021-2032)
  21. 6.9.2 South America Embolization Particle Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Embolization Particle Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Embolization Particle Sales Value Share by Country, 2025 VS 2032
7 Embolization Particle Country-level Sales and Value Analysis
  1. 7.1 Global Embolization Particle Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Embolization Particle Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Embolization Particle Sales by Country (2021-2032)
  4. 7.3.1 Global Embolization Particle Sales by Country (2021-2026)
  5. 7.3.2 Global Embolization Particle Sales by Country (2027-2032)
  6. 7.4 Global Embolization Particle Sales Value by Country (2021-2032)
  7. 7.4.1 Global Embolization Particle Sales Value by Country (2021-2026)
  8. 7.4.2 Global Embolization Particle Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Embolization Particle Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Embolization Particle Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Embolization Particle Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Embolization Particle Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Embolization Particle Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Embolization Particle Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Embolization Particle Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Embolization Particle Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Embolization Particle Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Embolization Particle Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Embolization Particle Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Embolization Particle Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Embolization Particle Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Embolization Particle Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Embolization Particle Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Embolization Particle Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Embolization Particle Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Embolization Particle Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Embolization Particle Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Embolization Particle Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Embolization Particle Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Embolization Particle Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Embolization Particle Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Embolization Particle Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Embolization Particle Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Embolization Particle Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Embolization Particle Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Embolization Particle Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Embolization Particle Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Embolization Particle Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Embolization Particle Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Embolization Particle Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Embolization Particle Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Embolization Particle Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Embolization Particle Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Embolization Particle Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Embolization Particle Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Embolization Particle Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Embolization Particle Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Embolization Particle Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Embolization Particle Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Embolization Particle Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Embolization Particle Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Embolization Particle Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Embolization Particle Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Embolization Particle Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Embolization Particle Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Embolization Particle Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Embolization Particle Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Embolization Particle Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Embolization Particle Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Embolization Particle Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Embolization Particle Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Embolization Particle Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Embolization Particle Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Embolization Particle Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Embolization Particle Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Embolization Particle Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Embolization Particle Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Embolization Particle Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Embolization Particle Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Embolization Particle Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Embolization Particle Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Embolization Particle Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Embolization Particle Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Embolization Particle Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Embolization Particle Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Embolization Particle Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Embolization Particle Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Embolization Particle Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Embolization Particle Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Embolization Particle Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Embolization Particle Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Embolization Particle Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Embolization Particle Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Embolization Particle Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Embolization Particle Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Embolization Particle Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Embolization Particle Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Embolization Particle Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Embolization Particle Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Embolization Particle Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Embolization Particle Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Embolization Particle Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sirtex Medical
  2. 8.1.1 Sirtex Medical Company Information
  3. 8.1.2 Sirtex Medical Business Overview
  4. 8.1.3 Sirtex Medical Embolization Particle Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sirtex Medical Embolization Particle Product Portfolio
  6. 8.1.5 Sirtex Medical Recent Developments
  7. 8.2 Merit Medical
  8. 8.2.1 Merit Medical Company Information
  9. 8.2.2 Merit Medical Business Overview
  10. 8.2.3 Merit Medical Embolization Particle Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Merit Medical Embolization Particle Product Portfolio
  12. 8.2.5 Merit Medical Recent Developments
  13. 8.3 Cook Medical
  14. 8.3.1 Cook Medical Company Information
  15. 8.3.2 Cook Medical Business Overview
  16. 8.3.3 Cook Medical Embolization Particle Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Cook Medical Embolization Particle Product Portfolio
  18. 8.3.5 Cook Medical Recent Developments
  19. 8.4 BTG Medical
  20. 8.4.1 BTG Medical Company Information
  21. 8.4.2 BTG Medical Business Overview
  22. 8.4.3 BTG Medical Embolization Particle Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 BTG Medical Embolization Particle Product Portfolio
  24. 8.4.5 BTG Medical Recent Developments
  25. 8.5 Boston Scientific Corporation
  26. 8.5.1 Boston Scientific Corporation Company Information
  27. 8.5.2 Boston Scientific Corporation Business Overview
  28. 8.5.3 Boston Scientific Corporation Embolization Particle Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Boston Scientific Corporation Embolization Particle Product Portfolio
  30. 8.5.5 Boston Scientific Corporation Recent Developments
  31. 8.6 Terumo Corporation
  32. 8.6.1 Terumo Corporation Company Information
  33. 8.6.2 Terumo Corporation Business Overview
  34. 8.6.3 Terumo Corporation Embolization Particle Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Terumo Corporation Embolization Particle Product Portfolio
  36. 8.6.5 Terumo Corporation Recent Developments
  37. 8.7 HENGRUI Medical
  38. 8.7.1 HENGRUI Medical Company Information
  39. 8.7.2 HENGRUI Medical Business Overview
  40. 8.7.3 HENGRUI Medical Embolization Particle Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 HENGRUI Medical Embolization Particle Product Portfolio
  42. 8.7.5 HENGRUI Medical Recent Developments
  43. 8.8 INterface BIOmaterials B.V.
  44. 8.8.1 INterface BIOmaterials B.V. Company Information
  45. 8.8.2 INterface BIOmaterials B.V. Business Overview
  46. 8.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 INterface BIOmaterials B.V. Embolization Particle Product Portfolio
  48. 8.8.5 INterface BIOmaterials B.V. Recent Developments
  49. 8.9 Alicon
  50. 8.9.1 Alicon Company Information
  51. 8.9.2 Alicon Business Overview
  52. 8.9.3 Alicon Embolization Particle Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Alicon Embolization Particle Product Portfolio
  54. 8.9.5 Alicon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Embolization Particle Value Chain Analysis
  2. 9.1.1 Embolization Particle Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Embolization Particle Sales Mode & Process
  6. 9.2 Embolization Particle Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Embolization Particle Distributors
  9. 9.2.3 Embolization Particle Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst